Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.

Introduction Biosimilar monoclonal antibodies (mAbs) are biologic drugs designed to be highly similar to already approved reference monoclonal ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

In July 2003. the company launched Lantus, the worlds first and only once a day insulin and in December 2003, Actonel, designed for the treatment of osteoporosis was launched.In the year 2004 ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

To find out how much insulin you need, it may help to calculate the insulin sensitivity factor. However, this calculation alone does not always determine how much insulin you need. The pancreas ...

The pancreas produces enzymes and hormones that help you digest food. One of these hormones, insulin, is necessary to regulate glucose. Glucose refers to sugars in your body. Every cell in your ...

SIRS 2022 New Med for Severe Mental Illness Tied to Less Weight Gain A recently approved drug is associated with less weight gain in patients with severe mental illness. At least one expert says ...